Finally, in MDSs and CMML, ASXL1 mutations seem to be present in chronic phases and precede transformation and in rare cases, ASXL1 mutations can be lost or acquired during relapse of de novo AML [29]. Here, ASXL1 is linked to chronic myelomonocytic leukemia.